Forms & publications for healthcare providers

Find documents including forms, provider publications, how-to-guides and e-commerce specifications. 

Provider demographic updates and contracting forms

Prior authorization

Product/network guides

 

Select “Date” or “Name” below to sort.

Date Sort ascending Name
06/23/2021 QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
06/23/2021 QP53-21 Medical Drug Exclusion List Update – for Euflexxa
06/09/2021 QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement
06/09/2021 QP49-21 Update for New to Market Medical Drugs: Anifrolumab, Teplizumab, Donislecel, and Difelikefalin
06/09/2021 QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021
06/09/2021 QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021
06/09/2021 QP48-21 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members
06/01/2021 P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
06/01/2021 P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
06/01/2021 P36-21 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update